GAA
PACB icon

Green Alpha Advisors’s Pacific Biosciences PACB Stock Holding History

Green Alpha Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Sell
178,655
-3,963
-2% -$5.76K 0.2% 85
2026
Q1 		$241K Sell
182,618
-848
-0.5% -$1.52K 0.24% 87
2025
Q4 		$343K Buy
183,466
+9,441
+5% +$18.1K 0.31% 85
2025
Q3 		$223K Sell
174,025
-32,998
-16% -$44.7K 0.22% 86
2025
Q2 		$257K Sell
207,023
-9,771
-5% -$11.3K 0.25% 88
2025
Q1 		$256K Buy
216,794
+114,373
+112% +$175K 0.27% 89
2024
Q4 		$187K Buy
102,421
+38,208
+60% +$74.6K 0.15% 129
2024
Q3 		$109K Buy
64,213
+30,117
+88% +$49.5K 0.09% 134
2024
Q2 		$46.7K Sell
34,096
-15,851
-32% -$32K 0.04% 137
2024
Q1 		$187K Buy
49,947
+8,512
+21% +$49.8K 0.14% 132
2023
Q4 		$406K Sell
41,435
-32,811
-44% -$268K 0.29% 118
2023
Q3 		$620K Sell
74,246
-36,865
-33% -$421K 0.48% 77
2023
Q2 		$1.48M Buy
111,111
+6,216
+6% +$75.5K 0.97% 33
2023
Q1 		$1.21M Buy
104,895
+437
+0.4% +$4.34K 0.85% 46
2022
Q4 		$854K Sell
104,458
-312
-0.3% -$2.69K 0.71% 56
2022
Q3 		$608K Sell
104,770
-318,066
-75% -$1.82M 0.52% 87
2022
Q2 		$1.87M Buy
422,836
+387,032
+1,081% +$2.35M 0.43% 55
2022
Q1 		$326K Buy
35,804
+7,757
+28% +$89.3K 0.22% 124
2021
Q4 		$574K Buy
28,047
+2,818
+11% +$68K 0.39% 103
2021
Q3 		$645K Buy
25,229
+4,950
+24% +$147K 0.45% 108
2021
Q2 		$709K Buy
+20,279
New +$590K 0.48% 103

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Green Alpha Advisors's PACB Position: Q2 2026 in Review

Green Alpha Advisors reduced its Pacific Biosciences (PACB) stake by 2.2% in Q2 2026, selling an estimated $5.76K and leaving 178,655 shares worth $300K. The position accounts for 0.2% of the portfolio, ranked #85.

Green Alpha Advisors first reported a position in PACB in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.87M in Q2 2022. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Green Alpha Advisors held 178,655 shares of Pacific Biosciences worth $300K as of Q2 2026.
  • Green Alpha Advisors sold 3,963 Pacific Biosciences shares in Q2 2026, an estimated $5.76K.
  • Pacific Biosciences made up 0.2% of Green Alpha Advisors's portfolio in Q2 2026, its #85 holding.
  • Green Alpha Advisors first reported a position in Pacific Biosciences in Q2 2021 and has held it in 21 quarters since.
  • Green Alpha Advisors's Pacific Biosciences position peaked at $1.87M in Q2 2022.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.